DS
NDRA icon

DRW Securities’s ENDRA Life Sciences NDRA Stock Holding History

DRW Securities’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,714
Closed -$68.4K – 1529
2025
Q3 		$68.4K Buy
+12,714
New +$66.4K ﹤0.01% 1211

Other funds holding NDRA

ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DRW Securities's NDRA Position: Q4 2025 in Review

DRW Securities sold out of ENDRA Life Sciences (NDRA) in Q4 2025, closing a stake of 12,714 shares — an estimated $68.4K sold.

DRW Securities first reported a position in NDRA in Q3 2025 and held it in 1 quarter. The position peaked at $68.4K in Q3 2025. 7 funds tracked by Wall St. Rank hold NDRA as of Q4 2025.

  • DRW Securities reported no remaining ENDRA Life Sciences position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 12,714 ENDRA Life Sciences shares in Q4 2025, an estimated $68.4K.
  • DRW Securities first reported a position in ENDRA Life Sciences in Q3 2025 and held it in 1 quarter.
  • DRW Securities's ENDRA Life Sciences position peaked at $68.4K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.